4.7 Review

Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart

期刊

CIRCULATION RESEARCH
卷 130, 期 9, 页码 1445-1465

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.121.319990

关键词

computed tomography; hemodynamics; magnetic resonance imaging; pulmonary hypertension; pulmonary vasculature; right ventricle; xenon MRI

资金

  1. Scleroderma Foundation
  2. United Therapeutics
  3. National Institutes of Health (NIH)
  4. National Heart, Lung and Blood Institute (NHLBI) [U01HL125175, R01HL134905, R01HL11490]
  5. Department of Defense [PR191839]
  6. Gossamer Bio, Inc.
  7. Regeneron Pharmaceutical, Inc.
  8. NIH, NHLBI [R01HL159443, R01HL131910]
  9. National Institute of Arthritis and Musculoskeletal and Skin diseases (NIAMS) [R01AR057374]
  10. Liquidia
  11. Janssen, United Therapeutics
  12. NIH [R01HL153872]
  13. National Institute of General Medical Sciences [R01GM122798]
  14. American Heart Association [TPA34880033]

向作者/读者索取更多资源

There is growing recognition of the significance of the right heart and pulmonary circulation in various disease states related to pulmonary hypertension and left heart failure. However, assessing the structure and function of the right heart and pulmonary circulation can be challenging due to complex factors such as the shape of the right ventricle and comorbidities. New imaging techniques show promise in providing more precise diagnostic information. These technologies have the potential to improve early diagnosis and noninvasive monitoring, leading to better patient care.
There is an increased appreciation for the importance of the right heart and pulmonary circulation in several disease states across the spectrum of pulmonary hypertension and left heart failure. However, assessment of the structure and function of the right heart and pulmonary circulation can be challenging, due to the complex geometry of the right ventricle, comorbid pulmonary airways and parenchymal disease, and the overlap of hemodynamic abnormalities with left heart failure. Several new and evolving imaging modalities interrogate the right heart and pulmonary circulation with greater diagnostic precision. Echocardiographic approaches such as speckle-tracking and 3-dimensional imaging provide detailed assessments of regional systolic and diastolic function and volumetric assessments. Magnetic resonance approaches can provide high-resolution views of cardiac structure/function, tissue characterization, and perfusion through the pulmonary vasculature. Molecular imaging with positron emission tomography allows an assessment of specific pathobiologically relevant targets in the right heart and pulmonary circulation. Machine learning analysis of high-resolution computed tomographic lung scans permits quantitative morphometry of the lung circulation without intravenous contrast. Inhaled magnetic resonance imaging probes, such as hyperpolarized 129Xe magnetic resonance imaging, report on pulmonary gas exchange and pulmonary capillary hemodynamics. These approaches provide important information on right ventricular structure and function along with perfusion through the pulmonary circulation. At this time, the majority of these developing technologies have yet to be clinically validated, with few studies demonstrating the utility of these imaging biomarkers for diagnosis or monitoring disease. These technologies hold promise for earlier diagnosis and noninvasive monitoring of right heart failure and pulmonary hypertension that will aid in preclinical studies, enhance patient selection and provide surrogate end points in clinical trials, and ultimately improve bedside care.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据